474 Federal Register / Vol. 84, No. 20 / Wednesday, January 30, 2019 / Notices 

DATES: The meeting will be held on 

March 14, 2019, 2:00 p.m. to 5:00 p.m., 

EDT (CLOSED). 

ADDRESSES: Teleconference. 

FOR FURTHER INFORMATION CONTACT: 

Gwendolyn H. Cattledge, Ph.D., 

M.S.E.H., Deputy Associate Director for 

Science, NCIPC, CDC, 4770 Buford 

Highway NE, Mailstop F–63, Atlanta, 

GA 30341, Telephone (770) 488–3953, 

Email address: NCIPCBSC@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

meeting will be closed to the public in 

accordance with provisions set forth in 

Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the 

Chief Operating Officer, Office of the 

Chief Operating Officer, CDC, pursuant 

to Public Law 92–463. 

Purpose: The Board of Scientific 

Counselors makes recommendations 

regarding policies, strategies, objectives, 

and priorities; and reviews progress 

toward injury and violence prevention. 

The Board also provides advice on the 

appropriate balance of intramural and 

extramural research, and guidance on 

the needs, structure, progress and 

performance of intramural programs. 

The Board also provides guidance on 

extramural scientific program matters, 

including the: (1) Review of extramural 

research concepts for funding 

opportunity announcements; (2) 

conduct of secondary peer review of 

extramural research grants, cooperative 

agreements, and contracts applications 

received in response to the funding 

opportunity announcements as they 

relate to the Center’s programmatic 

balance and mission; (3) submission of 

secondary review recommendations to 

the Center Director relating to 

applications to be considered for 

funding support; (4) review of research 

portfolios, and (5) review of program 

proposals. 

Matters to be Considered: The agenda 

will include discussions on Secondary 

Peer Review of extramural research 

grant and cooperative agreement 

applications received in response to one 

(1) Notice of Funding Opportunities 

(NOFO): CE19–001, Injury Control 

Research Centers. Agenda items are 

subject to change as priorities dictate. 

The Chief Operating Officer, Centers 

for Disease Control and Prevention, has 

been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2019–00298 Filed 1–29–19; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—DP19–005, Research 

to Enhance the US Vision and Eye Health 

Surveillance System. 

Dates: March 28, 2019. 

Times: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman Ph.D., Scientific Review Officer, CDC, 

4770 Buford Highway, Mailstop F80, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

kva5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2019–00275 Filed 1–29–19; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, DDK–C Member 

Conflicts. 

Date: February 15, 2019. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

7111, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7799, yangj@

extra.niddk.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 24, 2019. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00292 Filed 1–29–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


amozie on DSK3GDR082PROD with NOTICES1